Lehrstuhl für Haut- und Geschlechtskrankheiten

Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR (2022) Leiter-Stoppke U, Keim U, Amaral T, Forschner A, Berking C, Gesierich A, Gutzmer R, et al. Conference contribution The quality of national skin cancer screening from the perspective of general practitioners: A questionnaire-based comparison between Saxony and Bavaria (SaBaScreen) (2022) Strasser C, Reinhardt L, Steeb T, Wessely A, Schelling J, Petzold A, Heppt M, et al. Conference contribution SOX10-based drug repurposing identifies novel therapeutic targets in uveal melanoma (2022) Wessely A, Kammerbauer C, Lischer C, Weich A, Vera J, Berking C, Heppt M Conference contribution In vitro assessment of checkpoint-induced cytokine levels as new tool in the therapeutic decision-making process after checkpoint-induced cytokine release syndrome in metastatic melanoma (2022) Kramer R, Bender-Säbelkampf S, Berking C, Heppt M, Erdmann M, Bosch-Voskens C Conference contribution A single-center, retrospective Analysis for the Detection of Distant Metastases in Patients with regionally metastatic Melanoma in the Era of effective adjuvant Therapies (2022) Toussaint F, Kramer RA, Bender-Säbelkampf S, Hornung-Eichler A, Karimi B, Heppt M, Bosch-Voskens C, et al. Conference contribution Primary cutaneous manifestation of systemically aggressive diffuse large B-cell lymphoma (2022) Bender-Säbelkampf S, Spriewald B, Berking C, Erdmann M, Wagner N Conference contribution The soluble CD83 molecule accelerates wound closure and improves wound healing quality (2022) Royzman D, Peckert-Maier K, Stich L, Wild A, Ostalecki C, Seyferth S, Eming SA, et al. Conference contribution Pre-incubation of corneal donor tissue with soluble CD83 improves graft survival via the induction of pro-resolving macrophages (2022) Peckert-Maier K, Schoenberg A, Wild A, Royzman D, Braun G, Hadrian K, Tripal P, et al. Conference contribution Model soups improve performance of dermoscopic skin cancer classifiers (2022) Maron RC, Hekler A, Haggenmüller S, von Kalle C, Utikal JS, Müller V, Gaiser M, et al. Journal article The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis (2022) Royzman D, Andreev D, Stich L, Peckert K, Wild A, Zinser E, Mühl-Zürbes P, et al. Journal article